Evolution of the Incidence of Oral Cavity Cancers in the Elderly from 1990 to 2018.

elderly epidemiology incidence oral cavity cancer

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
30 Jan 2023
Historique:
received: 30 11 2022
revised: 12 01 2023
accepted: 17 01 2023
entrez: 11 2 2023
pubmed: 12 2 2023
medline: 12 2 2023
Statut: epublish

Résumé

To describe the evolution of the incidence of oral cavity cancers (OCC) among elderly patients in France between 1990 and 2018 and to compare it to the incidence of other cancers sharing the same main risk factors. The incidence of cancers in mainland France from 1990 to 2018 was estimated from incidence data observed in every cancer registry of the Francim network. Incidence was modeled by a 2-dimensional penalized spline of age and year of diagnosis, associated with a random effect corresponding to the registry. The elderly population was divided into two groups: 70-79 years old and ≥80 years old. There was a 72% increase in the number of OCC cases in women over 70 years of age between the periods 1990-1999 and 2010-2018. As for men, there was a stabilization in the number of cases (+2%). Over the same period, for laryngeal and hypopharyngeal cancers, there was a decrease in incidence in elderly men and an increase in elderly women, although less marked than for OCC. Since the 1990s, the incidence of OCC has been increasing in elderly subjects in France, particularly in women. Population aging and growth or alcohol and tobacco consumption alone do not seem to explain this increase, which is not observed in the same proportions for other upper aerodigestive tract cancer subsites sharing the same main risk factors.

Identifiants

pubmed: 36769722
pii: jcm12031071
doi: 10.3390/jcm12031071
pmc: PMC9917397
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Int J Epidemiol. 2020 Aug 1;49(4):1294-1306
pubmed: 32830255
Eur Arch Otorhinolaryngol. 2023 Jan;280(1):329-338
pubmed: 35857101
Cancer Causes Control. 2011 Sep;22(9):1217-31
pubmed: 21744095
Int J Oral Maxillofac Surg. 2022 Jan;51(1):18-26
pubmed: 33773877
Med Hypotheses. 2021 Mar;148:110507
pubmed: 33524846
Int J Cancer. 2009 Jun 1;124(11):2671-6
pubmed: 19230023
Eur J Cancer. 2017 Sep;82:115-127
pubmed: 28654785
Front Oncol. 2016 Aug 31;6:199
pubmed: 27630826
Oral Oncol. 2014 Nov;50(11):1058-61
pubmed: 25169920
BMC Cancer. 2014 Feb 15;14:94
pubmed: 24528929
Head Neck. 2008 Jan;30(1):75-84
pubmed: 17694557
Oral Oncol. 2015 Mar;51(3):229-36
pubmed: 25488179
Oral Oncol. 2009 Apr-May;45(4-5):309-16
pubmed: 18804401
J Otolaryngol Head Neck Surg. 2017 Sep 4;46(1):56
pubmed: 28870248
Dis Mon. 2020 Dec;66(12):100988
pubmed: 32605720
Eur J Cancer. 2004 Jan;40(1):96-125
pubmed: 14687795
Presse Med. 2017 Mar;46(3):320-330
pubmed: 28233703
Int J Cancer. 2015 Jul 15;137(2):448-62
pubmed: 25627906
Oral Oncol. 2002 Jun;38(4):391-3
pubmed: 12076705
Int J Cancer. 2016 Aug 1;139(3):574-83
pubmed: 27038013
BMC Cancer. 2015 Oct 31;15:827
pubmed: 26520570
Int J Cancer. 2015 Feb 15;136(4):904-14
pubmed: 24974959
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
Acta Oncol. 2016;55 Suppl 1:13-8
pubmed: 26760291
Oral Oncol. 2020 Mar;102:104551
pubmed: 31986342
Eur Arch Otorhinolaryngol. 2022 Jan;279(1):415-424
pubmed: 33877432
Oral Dis. 2015 Sep;21(6):685-93
pubmed: 25809224
J Dent Res. 2020 Feb;99(2):143-151
pubmed: 31874128
JAMA Oncol. 2018 Mar 01;4(3):358-365
pubmed: 29327043
JAMA Otolaryngol Head Neck Surg. 2015 Jan;141(1):5-11
pubmed: 25375930
BMJ Open. 2017 Jan 9;7(1):e012833
pubmed: 28069619
Oral Oncol. 2014 Jun;50(6):616-25
pubmed: 24680035
Tob Induc Dis. 2021 Jul 19;19:60
pubmed: 34305506

Auteurs

Alice Renou (A)

Department of Surgery, University Cancer Institute Toulouse-Oncopole, Hôpitaux Universitaires de Toulouse, 31009 Toulouse, France.

Anne-Valérie Guizard (AV)

French Network of Cancer Registries, 31073 Toulouse, France.
General Tumor Registry of Calvados, Centre François Baclesse, 14000 Caen, France.
ANTICIPE U 1086 Inserm-UCN, 14000 Caen, France.

Emilien Chabrillac (E)

Department of Surgery, Institut Claudius Regaud, University Cancer Institute Toulouse-Oncopole, 31009 Toulouse, France.

Gautier Defossez (G)

French Network of Cancer Registries, 31073 Toulouse, France.
General Cancer Registry of Poitou-Charentes, Pôle Biologie, Pharmacie et Santé Publique, CHU/Université de Poitiers, 86000 Poitiers, France.

Pascale Grosclaude (P)

French Network of Cancer Registries, 31073 Toulouse, France.
Tarn Cancer Registry, Claudius Regaud Institute, University Cancer Institute Toulouse-Oncopole, 31009 Toulouse, France.
CERPOP, UMR 1295 Inserm Toulouse III University, 31000 Toulouse, France.

Sophie Deneuve (S)

Department of ENT, Rouen University Hospital, 76000 Rouen, France.
Quantification en Imagerie Fonctionnelle-Laboratoire d'Informatique, du Traitement de l'Information et des Systèmes Equipe d'Accueil 4108 (QuantIF-LITIS EA4108), University of Rouen, 76000 Rouen, France.

Sébastien Vergez (S)

Department of Surgery, University Cancer Institute Toulouse-Oncopole, Hôpitaux Universitaires de Toulouse, 31009 Toulouse, France.

Bénédicte Lapotre-Ledoux (B)

French Network of Cancer Registries, 31073 Toulouse, France.
Somme Cancer Registry, CHU Amiens, CEDEX 1, 80054 Amiens, France.
CHIMERE, Surgery, Imaging and Tissue REgeneration of the Cephalic Extremity-Morphological and Functional Characterization, 7516 UR UPJV, CHU-Amiens Picardie, 1 Rond Point du Professeur Cabrol, 80000 Amiens, France.

Sandrine D Plouvier (SD)

French Network of Cancer Registries, 31073 Toulouse, France.
General Cancer Registry of Lille Area, GCS-C2RC, 59000 Lille, France.

Agnès Dupret-Bories (A)

Department of Surgery, University Cancer Institute Toulouse-Oncopole, Hôpitaux Universitaires de Toulouse, 31009 Toulouse, France.

Classifications MeSH